5,534 Shares in Align Technology, Inc. $ALGN Bought by Impact Partnership Wealth LLC

Impact Partnership Wealth LLC acquired a new position in Align Technology, Inc. (NASDAQ:ALGNFree Report) in the 1st quarter, Holdings Channel.com reports. The firm acquired 5,534 shares of the medical equipment provider’s stock, valued at approximately $949,000.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. Banco Bilbao Vizcaya Argentaria S.A. increased its holdings in shares of Align Technology by 3.7% in the 4th quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 1,896 shares of the medical equipment provider’s stock valued at $296,000 after purchasing an additional 68 shares in the last quarter. Blue Trust Inc. lifted its stake in shares of Align Technology by 77.5% in the first quarter. Blue Trust Inc. now owns 158 shares of the medical equipment provider’s stock valued at $27,000 after purchasing an additional 69 shares during the period. Comerica Bank boosted its holdings in Align Technology by 0.6% during the fourth quarter. Comerica Bank now owns 13,656 shares of the medical equipment provider’s stock worth $2,132,000 after buying an additional 76 shares in the last quarter. Independence Bank of Kentucky grew its position in Align Technology by 77.7% during the fourth quarter. Independence Bank of Kentucky now owns 183 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 80 shares during the period. Finally, Allworth Financial LP grew its position in Align Technology by 3.3% during the third quarter. Allworth Financial LP now owns 2,874 shares of the medical equipment provider’s stock worth $360,000 after buying an additional 92 shares during the period. Institutional investors and hedge funds own 88.43% of the company’s stock.

Align Technology Stock Performance

Align Technology stock opened at $168.66 on Wednesday. Align Technology, Inc. has a fifty-two week low of $122.00 and a fifty-two week high of $208.30. The company has a market capitalization of $12.08 billion, a price-to-earnings ratio of 28.30, a PEG ratio of 1.78 and a beta of 1.67. The stock has a fifty day moving average of $172.45 and a two-hundred day moving average of $172.68.

Align Technology (NASDAQ:ALGNGet Free Report) last issued its quarterly earnings data on Wednesday, April 29th. The medical equipment provider reported $2.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.26 by $0.32. The business had revenue of $1.04 billion for the quarter, compared to the consensus estimate of $1.02 billion. Align Technology had a return on equity of 15.82% and a net margin of 10.50%.The business’s revenue was up 6.2% on a year-over-year basis. During the same period in the prior year, the business earned $2.13 earnings per share. On average, analysts forecast that Align Technology, Inc. will post 9.48 EPS for the current fiscal year.

Align Technology announced that its Board of Directors has approved a share repurchase program on Wednesday, April 29th that permits the company to buyback $200.00 million in shares. This buyback authorization permits the medical equipment provider to purchase up to 1.6% of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s board of directors believes its stock is undervalued.

Analysts Set New Price Targets

A number of brokerages have issued reports on ALGN. Citigroup assumed coverage on shares of Align Technology in a report on Wednesday, April 15th. They issued a “buy” rating and a $240.00 target price for the company. Piper Sandler upped their price target on Align Technology from $220.00 to $235.00 and gave the stock an “overweight” rating in a report on Tuesday, April 21st. Wall Street Zen downgraded Align Technology from a “strong-buy” rating to a “buy” rating in a research note on Saturday, June 13th. Barclays upgraded Align Technology from an “equal weight” rating to an “overweight” rating and set a $200.00 target price on the stock in a research report on Tuesday, March 17th. Finally, Zacks Research raised Align Technology from a “hold” rating to a “strong-buy” rating in a report on Monday, June 1st. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $205.85.

Check Out Our Latest Stock Analysis on Align Technology

Align Technology Company Profile

(Free Report)

Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.

Featured Articles

Want to see what other hedge funds are holding ALGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Align Technology, Inc. (NASDAQ:ALGNFree Report).

Institutional Ownership by Quarter for Align Technology (NASDAQ:ALGN)

Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.